|
Odds ratio
|
95% CI
|
Dose/duration
|
Aspirin
|
Peleg and coworkers4
| 0.08 | 0.01–0.59 | >624 days any dose |
| 0.52 | 0.30–0.91 | <208 days any dose |
Rosenberg and coworkers5
| 0.5 | 0.4–0.8 | 1 year or more any dose |
| 0.5 | 0.2–0.9 | <1 year any dose |
Kune and coworkers6
| 0.53 | 0.40–0.71 | Any dose or duration |
Giovannucci and coworkers7
| 0.09 | 0.02–0.43 | Over 5 years1-150 |
| 0.23 | 0.09–0.54 | Over 3 years1-151
|
| 0.52 | 0.32–0.84 | In 1 year1-152 |
Logan and coworkers8 (adenomas) | 0.72 | 0.4–1.3 | Any use |
Non-aspirin NSAID
|
Peleg and coworkers4
| 0.34 | 0.15–0.77 | >350 days |
| 0.77 | 0.48–1.23 | <350 days |
Kune and coworkers6
| 0.77 | 0.60–1.01 | Any use |
Aspirin or non-aspirin NSAID
|
Logan and coworkers8(adenomas) | 0.72 | 0.3–1.6 | Prescribed use |